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OBJECTIVES: To clarify differences between solitary pulmonary inflammatory lesions and peripheral lung
cancers with contrast-enhanced computed tomography.
METHODS: In total, 64 and 132 patients with solitary pulmonary inflammatory masses/nodules and peripheral
lung cancers, respectively, were enrolled in this study. Their computed tomographic findings were summarized
and compared retrospectively.
RESULTS: Compared with the peripheral lung cancers, the inflammatory lesions were located closer to the
pleura (po0.0001). The majority of the inflammatory lesions were patchy and oval-shaped (82.8%), whereas
most of the tumors were lobulated (82.6%). Almost all the inflammatory cases were unclear (93.8%), whereas
most of the tumors had spiculated margins (72.7%). Computed tomography values were significantly higher for
the inflammatory lesions than for the cancers (po0.0001). More than half of the inflammatory lesions had
defined necrosis (59.3%). Furthermore, 49.2% of the cancers enhanced inhomogeneously, but only 24.6% had
ill-defined necrosis or cavities. The peripheral zones of 98.4% of the inflammatory lesions and 72.7% of the
tumors were unclear, with peripheral scattered patches (92.2%) and beam-shaped opacity (66.7%) being the
most common findings, respectively. Adjacent pleural thickening was more frequent for the inflammatory
lesions than the cancers (95.3% vs. 21.1%, po0.0001), whereas pleural indentation was found in 67.4% of the
subjects with cancer. In addition, hilar (p=0.034) and mediastinal (p=0.003) lymphadenopathy were more
commonly detected in the cancers than in the inflammatory cases.
CONCLUSIONS: Contrast-enhanced computed tomography findings for pulmonary inflammatory lesions and
peripheral lung cancers were significantly different in many aspects. Developing a comprehensive under-
standing of these differences is helpful for directing their management.
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’ INTRODUCTION
Focal pulmonary lesions, which can be nodules or masses,
are commonly encountered in clinical practice (1) and can be
benign or cancerous. Common diagnostic methods for eval-
uating such lesions include sputum cytology, bronchoscopy,
and transthoracic needle biopsy, depending on lesion loca-
tion (1). In addition to these examinations, noninvasive pro-
cedures, especially computed tomography (CT), are also
commonly applied to localize lesions and provide essential
diagnostic information.
Inflammation and lung cancer are the most common types
of pulmonary benign and malignant lesions, respectively. On
chest CT scanning, most solitary pulmonary inflammatory
lesions are found in the lung fields adjacent to the pleura.
Peripheral lung cancers, predominantly adenocarcinoma
and squamous cell carcinoma, are also usually located in
these zones. These two lesion types typically exhibit similar
CT manifestations; however, the procedures used to treat
them are substantially different. Therefore, it is necessary to
carefully distinguish these lesion types based on their CT
characteristics.
Isolated pulmonary inflammatory lesions have an
unknown etiology, but they are usually associated with a
focal, uncontrolled inflammatory response to infection with
bacteria, viruses or other organisms. The pathological course
of this type of lesion mainly includes accumulation of multi-
ple types of inflammatory cells as well as alteration and
exudation, whereas that for lung cancer lesions includesDOI: 10.6061/clinics/2016(10)01
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abnormal cell proliferation and invasion into surrounding
tissue. Focal inflammation can easily result in a peripheral
response that includes exudation and edema. Meanwhile,
infiltration and disruption of mesenchyme usually occur
during tumor growth and these processes further affect
surrounding structures (2-4). These pathological differences
suggest that observable differences in CT manifestations may
also exist.
Several previous studies have focused on differentiating
benign and malignant pulmonary nodules (p3 cm) with CT
through evaluations of morphology, perfusion or growth rate
(2,5-10). However, in all of the referenced studies, the sample
size for benign nodules was very small and their patholo-
gical nature was extremely diverse. Furthermore, although
inflammatory lesions were studied, their CT characteristics
remained poorly understood. To date, no relevant study has
comprehensively distinguished solitary inflammatory lesions
from peripheral lung cancers using CT. Therefore, the aim
of the current study was to clarify the CT characteristics of
these two common conditions by comprehensively evaluating
representative lesions and their surroundings. The provided
information may be helpful for directing further management
of these lesions.
’ MATERIALS AND METHODS
Patients
From 1 July 2012 to 31 December 2014, we collected CT
data on patients with solitary pulmonary nodules or masses
who consecutively underwent surgical resection (140 cases),
bronchoscopy (76 cases), or transthoracic needle biopsy
(37 cases) in departments of thoracic surgery and respiratory
medicine. The authors had access to identifying information
after data collection. Patients with confirmed solitary inflam-
matory lesions or peripheral lung cancers and those who had
complete clinical and contrasted-enhanced CT data were
included in this study. Lesions that were too large to generate
adequate descriptions of their surrounding structures were
excluded (3 cases). In addition, pathologically confirmed soli-
tary tuberculosis (5 cases), fungal infection (3 cases) and
noninfectious lesions (2 cases) were not evaluated in this study
because of small sample sizes and the differences in their
associated pathological processes. Moreover, pulmonary
inflammatory pseudotumors were also excluded because they
usually had distinct characteristics, appearing as asympto-
matic, solitary, peripheral, sharply circumscribed masses with
heterogeneous CT attenuation (11). No patients were excluded
due to lack of information. In total, 64 patients with solitary
inflammatory lesions and 132 with peripheral lung cancers
were enrolled in this study. The collected clinical data included
age, sex, smoking history, and clinical manifestations. Labora-
tory results included routine blood examinations for the
patients with inflammatory lesions.
CT Protocol
All patients were examined with a 64-multidetector CT
scanner (LightSpeed VCT; GE Healthcare, Waukesha, WI,
USA) with the following parameters: 120 kVp; 250 mAs;
rotation time, 0.6 s; pitch, 0.984; collimation, 0.625 mm; slice
thickness and interval for axial images, 5 mm/5 mm. The
patients were placed in a supine position with both hands
placed near the head when they underwent CT examination.
Acquisition was performed from the level of the thoracic
inlet to immediately inferior to the costophrenic angle. All
patients underwent plain and enhancement CT scanning
with a total of 80–100 mL (1.35 mL per kilogram of body
weight) of nonionic iodinated contrast material ([Iopamidol],
320 mg/mL; Shanghai Bracco Sine Pharmaceutical Co., Ltd.,
China) at an injection rate of 3.0 mL/s, followed by 50 mL of
saline solution via a power injector. Images were obtai-
ned with mediastinal (width, 350–450 HU; level, 20–40 HU)
and lung (width, 1200–1600 HU; level,  500 to  700 HU)
window settings.
Image Analysis
All patients’ CT data were reviewed on a workstation
(Advantage Workstation 4.6; GE Healthcare) by two senior
chest radiologists who were blinded to the final results of the
lesions. Interpretation discrepancy, if any, was resolved by
consensus.
The numbers of lesions in different lobes (left superior
and inferior lobes; right superior, middle, and inferior lobes)
were counted. The locations of lesions were described
according to the distance between them and the adjacent
pleura. For these locations, two conditions were considered:
space vs. no space. If space was observed, the distance
between the lesions and the pleura was measured. Lesion
shape was described as patchy (rectangular, triangular, or
trapezoidal), oval, round, lobulated, or irregular. Lobulated
lesions had an undulating contour, while irregular ones had
an uneven shape that could not be characterized as patchy,
oval, round, or lobulated. Lesion margins were described as
unclear, smooth, or spiculated. Lesion size was calculated as
half of the sum of the long and short transverse diameters.
CT manifestations in the peripheral zones of the lesions
were described as follows: scattered patches, beam-shaped
opacity (Figure 1), nodules, fibrosis, halo signs and con-
solidation. Density and CT values were measured on plain
and enhanced CT images. The enhanced CT value (DCT) was
calculated to describe the degree of enhancement. On
enhanced CT images, we determined whether necrosis was
present in the lesions. The changes to the pleura adjacent to
the lesions included significant, mild, or zero thickening and
pleural indentation. Pleural effusions and lymph nodes in
the hilum and mediastinum were also evaluated. Enlarged
mediastinal and hilar lymph nodes were generally defined
on chest CT scans as those with a diameter 41 cm in the
short axis (12,13).
Statistical Analysis
Clinical data, laboratory results, and various CT features
were statistically analyzed for each patient. Continuous
variables were expressed as the mean±SD, whereas catego-
rical variables were expressed as numbers and percentages.
A chi-square test was used to compare the frequencies of dif-
ferent clinical symptoms and CT features between inflam-
matory lesions and peripheral lung cancers. Independent
sample t-tests were used to compare age; smoking index; and
size, density and DCT of lesions between patients with
inflammatory lesions and those with peripheral lung cancers.
To determine the effect of DCT on differentiating inflamma-
tory from neoplastic lesions, receiver operating characteristic
(ROC) analysis was performed. All analyses were performed
with the statistical package SPSS (version 18.0 for Windows,
SPSS Inc., Chicago, Illinois, USA). Two-tailed p-values of
o0.05 were considered statistically significant.
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’ RESULTS
Study Population
All the patients’ baseline clinical data and laboratory
results are summarized in Table 1. The patients with lung
cancers were older than those with inflammatory lesions
(p=0.003). Compared with the lung cancer group, there were
more male patients (84.3% vs. 65.1%, p=0.005) and more
cases with respiratory symptoms such as cough, expectora-
tion, phlegm with blood, and chest pain (93.8% vs. 49.2%,
p=0.005) in the inflammation group.
Pathologic
Pathologically, the peripheral lung cancer cases included
97 (73.5%) adenocarcinomas, 31 (23.5%) squamous carcino-
mas, three (2.3%) adenosquamous carcinomas and one
(0.7%) mucoepidermoid carcinoma. As for the inflammatory
lesions, the excised specimens were usually irregular in
shape, grayish white in color, and had no clear boundary
with adjacent lung tissue. Additionally, the texture of the
lesions was rubbery. The terminal bronchioles in the masses
proliferated and dilated, and multinucleated giant cells and
neutrophils could be observed. Plasma cells and lympho-
cytes were distributed around bronchial walls. Alveolar
epithelium actively proliferated, which resulted in focal
pulmonary carnification. Large numbers of foam cells were
detected in the alveolar spaces. Fibrous tissue proliferation
with hyaline and myxoid degeneration occurred in the
alveolar septa. Additionally, localized abscess formation
could be detected in some lesions.
Lesion Locations
The locations of the inflammatory lesions and lung cancers
are summarized in Table 2. The numbers of inflammatory
lesions distributed in the superior and inferior lobes of the
lungs were the same. In contrast, the cancers were more
frequently found in the two superior lobes. Considering the
distance between the lesions and the pleura, the inflamma-
tory cases were more often found close to the pleura than
were the cancers (po0.0001). For the lesions in close proxi-
mity to the pleura, the inflammatory lesions usually had
a broad basement (Figure 2), while acute angles between
the cancerous nodules and the pleura were generally
observed.
CT Characteristics of Lesions
The CT characteristics of the solitary inflammatory lesions
and the peripheral lung cancers are summarized in Table 3.
The majority of the inflammatory lesions were patchy and
oval-shaped (53 cases, 82.8%). In contrast, most of the lung
cancers were lobulated (109 cases, 82.6%). Considering their
interfaces, 60 (93.8%) inflammatory cases were unclear and
Figure 1 - Beam-shaped opacity. Beam-shaped opacity refers to
the shadow with ground glass opacity located at the side of a
tumor close to the pleura. It is usually curved and has different
directions, similarly to a light beam (arrows).
Table 1 - Patients’ characteristics and laboratory results.
Patients with IL
(n=64)
Patients with PLC
(n=132)
p-value
Age (years) 56±11 61±9 0.003
Men/women 54/10 86/46 0.005
Smokers 39 (60.9%) 81 (61.3%) 0.954
Smoking index 570±375 973±1746 0.050
Fever 14 (21.9%) N -
Cough 48 (75%) 51 (38.6%) 0.000
Expectoration 40 (62.5%) 32 (24.2%) 0.000
Phlegm with blood 26 (40.6%) 10 (7.6%) 0.000
Chest pain 19 (29.7%) 15 (11.3%) 0.001
Hemoptysis 2 (3.1%) 5 (3.7%) 0.815
No symptoms 4 (6.2%) 67 (50.8%) 0.000
WBC count (109) 7.3±2.5 N -
Note: IL = Inflammatory lesion; PLC = Peripheral lung cancer; WBC= White blood cell; N = Not mentioned.
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96 (72.7%) cancers were spiculated (Figures 2 and 3). The
densities of the inflammatory and carcinoid lesions mea-
sured with plain CT were similar (p=0.088); however, DCT
values were significantly higher for the inflammatory lesions
than for the cancers (po0.0001). The diagnostic performance
of DCT in diagnosing inflammatory lesions and peripheral
lung cancers, expressed as an area under the curve (AUC),
was 0.765 (95% CI: 0.699, 0.822; po0.0001) with a cutoff of
40 HU. The sensitivity and specificity for inflammatory
lesions were 81.3% and 64.4%, while those for peripheral
lung cancers were 64.4% and 81.3%, respectively. On
enhanced images, more than half of the inflammatory cases
exhibited necrosis (38 cases, 59.3%), which usually mani-
fested as a rounded and clear low-density area without
enhancement (Figure 2), and 16 of these cases (42.1%) had
pneumatosis. For the lung cancer cases, 65 cases (49.2%)
enhanced inhomogeneously (Figure 3), and 16 of these cases
(24.6%) had ill-defined necrosis or cavities. Necrosis was
more commonly detected in the inflammatory lesions than in
the cancers (po0.0001).
Lesion Surroundings
The peripheral lung field of 63 (98.4%) of the inflammatory
lesions was unclear. Scattered patches, small nodules, or
fibrosis could be detected. Beam-shaped opacity, small
patches and halo signs were common manifestations around
the cancers. Scattered patches (59 cases, 92.2%) and beam-
shaped opacity (88 cases, 66.7%) were the most common
signs observed in the peripheral zones of the inflammatory
lesions and cancers, respectively (Figures 2 and 3). Further-
more, beam-shaped opacity was more common in adeno-
carcinomas and cancers with spiculation than in other
pathological types and cases with smooth margins [74.2%
(72 cases) vs. 45.7% (16 cases); 86.5% (83 cases) vs. 13.9%
(5 cases); both po0.0001] (Figure 3). The number of cases
with pleural thickening in the patients with inflammatory
and carcinoid lesions were 61 (95.3%) and 23 (17.4%),
respectively, and this difference was significant (po0.0001).
Additionally, significant pleural thickening was more com-
mon in the patients with inflammatory lesions (po0.0001)
(Figure 2). Pleural indentation was found in 89 (67.4%)
Table 2 - Locations of the inflammatory masses and lung cancers.
Patients with IL
(n=64)
Patients with PLC
(n=132)
p-value
Right lung SL 17 (26.6%) 38 (28.7%) -
ML 2 (3.1%) 15 (11.3%) -
IL 14 (21.9%) 21 (15.9%) -
Left lung SL 14 (21.9%) 35 (26.5%) -
IL 17 (26.6%) 23 (17.4%) -
Distance to the pleura Yes 4 (6.2%)(1.2-2.7 cm) 89 (67.4%)(0.2-3.6 cm) 0.000
No 60 (93.8%) 43 (32.6%) 0.000
SL= Superior lobe; ML= Middle lobe; IL = Inferior lobe.
Figure 2 - An inflammatory patch in a 48-year-old man with cough, expectoration and chest pain. There is a subpleural patch in the
superior lobe of the left lung. Its interface is ill-defined, and ground glass opacity can be detected in the peripheral lung field (A). The
basement of the lesion is broad. On the enhanced image, there is a low-density area with a clear boundary in it, which indicates
necrosis. Significant pleural thickening (arrows) can be seen (B).
558
Pulmonary Inflammatory Lesions and Cancer
Chu ZG et al.
CLINICS 2016;17(10):555-561
subjects with cancer, whereas the patients with inflammatory
lesions did not exhibit this characteristic.
Pleural Cavities and Lymph Nodes in the Hilum
and Mediastinum
Hilar and mediastinal lymphadenopathy was more com-
mon in the subjects with lung cancer than in those with
inflammatory lesions (hilar: 39.4% vs. 18.7%, p=0.034;
mediastinal: 32.5% vs. 12.5%, p=0.003). Pleural effusion was
rare in both inflammatory lesions and lung cancers, with
only three (4.7%) and nine (6.8%) patients exhibiting this
characteristic, respectively.
’ DISCUSSION
In the present study, a comparison of isolated inflamma-
tory lesions and peripheral lung cancers indicated many
significant differences in their corresponding CT findings.
These CT characteristics reflected their different pathological
bases and could be used to differentiate the lesions from each
other.
Theoretically, pulmonary inflammatory lesions and per-
ipheral lung cancers can occur at any lobe site; however, the
present results showed that they had distinct distribution
tendencies. Another study of small solitary pulmonary
nodules detected during population-based CT screening for
Table 3 - Characteristics of the inflammatory lesions and peripheral lung cancers.
Patients with IM
(n=64)
Patients with PLC
(n=132)
p-value
Shape Patchy 30 (46.9%) - -
Irregular 4 (6.3%) - -
Lobulated - 109 (82.6%) -
Oval 23 (35.9%) 10 (7.6%) 0.000
Round 7 (10.9%) 13 (9.8%) 0.813
Margins Unclear 60 (93.8%) - -
Smooth 4 (6.2%) 36 (27.3%) 0.000
Spiculation N 96 (72.7%)
Size (LD + SD)/2(cm) 3.3±1.2 (1.1-6.2) 3.2±1.1 (1.2-7.2) 0.509
Density Plain CT value (HU) 30.9±12.6 27.0±15.7 0.088
D CT value (HU) 51.1±14.8 36.4±16.0 0.000
Necrosis 38 (59.3%) 16 (12.1%) 0.000
Pneumatosis 16 (42.1%) N
Pleural thickening Significant 33 (51.6%) 4 (3.0%) 0.000
Mild 28 (43.7%) 19 (14.4%) 0.000
No 3 (4.7%) 109 (82.6%) 0.000
LD = Long diameter; SD = Short diameter; D CT= Peak CT value on contrast enhanced CT scan – CT value on plain CT scan; N = None; - = Not applicable.
Figure 3 - A peripheral pulmonary adenocarcinoma in a 49-year-old man with cough. A lobulated mass with spiculated margin located
in the superior lobe of right lung. Beam-shaped opacity (arrow) can be detected in the peripheral lung field (A). On the enhanced
image, an irregular low-density area with no clear boundary is seen (B).
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lung cancer showed similar results (14). This finding may
have arisen because of the developmental differences
associated with the two lesion types. For inflammatory
lesions, the exudate usually begins in the distal air spaces
adjacent to the visceral pleura; in contrast, peripheral lung
cancers usually derive from distal bronchia. Thus, the gaps
between the tumors and the pleura would show differences
at early stages, until the lesions grew large enough to involve
the chest wall (15). For subpleural lesions with pleural
thickening, the lung cancers usually caused mild thickening
due to focal invasion, whereas the inflammatory lesions
usually resulted in obvious thickening. These differences
may be helpful for differentiating the two conditions.
The inflammatory lesions usually did not have smooth
margins or clean peripheral lung fields due to the inflam-
matory process (16). In contrast, the lung cancers usually
had a lobulated appearance with spiculated margins. These
differences can be attributed to the different growth rates of
cancerous cells with different differentiations, the contraction
of inner fibrosis, and the growth of tumor cells along the
pulmonary interstitium (2-4,16-18). For some of the periph-
eral lung cancers in this study, pleural indentation was
commonly detected, which was usually caused by the
contraction of fibrous tissue inside the lesions (2). However,
this characteristic was not specific because similar findings,
including local pleural adhesion and the presence of pleural
tags, can also be detected in small benign lung nodules
(14,19). In benign lesions, these features are probably caused
by a local process associated with inflammation. Thus, other
characteristics of the lesions should be considered for dis-
criminating lung nodules with such manifestations.
In the present study, an interesting CT feature was
revealed for peripheral lung cancers, namely, the presence
of beam-shaped opacity, which has not been described
previously. This characteristic was commonly detected in
adenocarcinomas, especially those with spiculation. This
finding may be a consequence of tumor mesenchyme
contraction resulting in corresponding alveoli collapse, with
the decrease of gas in the alveolar space increasing the local
attenuation. However, further research is needed to under-
stand the pathological nature of this novel CT feature and to
determine whether it is specific to lung cancer.
On contrast-enhanced images, the inflammatory lesions
usually showed a higher peak enhancement than the lung
cancers, and clear necrosis was more commonly detected in
them. Previous studies have also confirmed this finding
(10,20). The likely explanation for these discrepancies is that
active inflammatory responses usually result in dilatation of
local vessels and central liquefaction necrosis, while malig-
nant tumor growth is a relatively slow process that involves
neovascularization, in which degeneration is common but
significant necrosis is rare. ROC curve analysis showed that
peripheral lesions with DCT values greater than 40 HU were
more likely to be inflammatory lesions. However, for lesions
with DCT values lower than 40 HU, especially those with
slight and no enhancement, benign lung nodules, such as
tumors, chronic inflammation, and inactive tuberculomas,
should be considered (21,22).
Thoracic lymphadenopathy may be another useful char-
acteristic for differentiating the two conditions studied here.
Focal inflammatory lesions usually exhibited only hilar
lymphadenopathy, while both hilar and mediastinal lym-
phadenopathy were usually detected in lung cancers due to
metastasis. In addition, patients’ clinical symptoms should
also be considered, although they may not be specific for any
disease. In the present study, a greater number of patients
with inflammatory lesions had chest symptoms than those
with lung cancer. A previous study indicated that, although
approximately 10% of lung cancers are detected in asympto-
matic patients on chest radiography, most patients are
symptomatic when diagnosed (23). These symptoms may
be related to metastasis. Thus, for patients without chest
symptoms, a careful determination of clinical history may
provide useful diagnostic information.
In addition to CTexamination, dynamic contrast-enhanced
magnetic resonance (MRI) with quantitative diffusion-
weighted imaging has also been used to determine whether
solitary pulmonary lesions are benign or malignant (24).
In addition, 2-[F-18] fluoro-2-deoxy-D-glucose-positron emis-
sion tomography (FDG-PET) is considered a superior pre-
dictor of malignancy in solitary pulmonary nodules (p3 cm)
without cavities or calcification (25). These noninvasive
imaging methods can provide additional data for discrimi-
nating pulmonary benign and malignant lesions.
There were several limitations in the current study. First,
large or extensive lesions were not studied because they
could be easily distinguished and their surrounding features
are difficult to evaluate. In contrast, differentiating smaller
lesions is usually difficult in clinical practice. Second, we
only reported the number of patients with lung cancers who
had hilar or mediastinal lymphadenopathy, whereas whether
they had metastasis was not clear because not all lymph
nodes were resected. Indeed, lymphadenopathy was only a
factor used for differentiating between lesions and whether
metastasis was present was not important for the results.
Third, all of the aforementioned characteristics were not
sufficient for differentiating extremely small lesions. For
these cases, CT-guided percutaneous transthoracic biopsy
may be more useful. Finally, diagnostic imaging still should
not replace pathological examination because none of the
summarized CT features for discriminating between lesion
types were specific.
In conclusion, solitary pulmonary inflammatory lesions
and peripheral lung cancers have several distinct CT features
that could be helpful in their differentiation. Subpleural ir-
regular patchy or oval-shaped lesions with defined necrosis,
unclear margins and peripheral lung fields as well as sig-
nificant enhancement and pleural thickening were usually
inflammatory lesions, while lobulated lesions distant from
the pleura with inhomogeneous enhancement, spiculated
interfaces, pleural indentation, and beam-shaped opacity
were usually lung cancer. Understanding these differences
is helpful for initially determining lesion type and then
selecting whether early intervention should involve invasive
examination, surgery or anti-inflammatory treatment and to
support further observations with serial CT.
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